Cleared Traditional

018 Hydrophilic Coated OTW PTA Balloon Dilatation Catheter (K180007) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180007 · Creagh Medical, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2018
Decision
107d
Days
Class 2
Risk

K180007 is an FDA 510(k) clearance for the 018 Hydrophilic Coated OTW PTA Balloon Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Creagh Medical, Ltd. (Ballinasloe, IE). The FDA issued a Cleared decision on April 19, 2018 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Creagh Medical, Ltd. devices

Submission Details

510(k) Number K180007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 02, 2018
Decision Date April 19, 2018
Days to Decision 107 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 125d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Dba Surmodics, Inc.
Sherri Mellingen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 177
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K180007.
Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection
K181529 · Contego Medical, LLC · Dec 2018
Paladin Carotid Post-dilation Balloon System with Integrated Embolic Protection (Paladin System)
K181128 · Contego Medical, LLC · Sep 2018
Atlas Gold PTA Dilatation Catheter
K181323 · C.R. Bard, Inc. · Aug 2018
Admiral Xtreme
K173515 · Medtronic Vascular · Apr 2018
Jade PTA Balloon Dilatation Catheter
K173894 · Orbusneich Medical Trading, Inc. · Feb 2018
Advocate PTA Catheter
K173621 · Merit Medical Systems, Inc. · Dec 2017